archived version — not current
This is a permanent, read-only archive of this profile's public content as it existed on 2026-09-27. It does not reflect the current, live profile. View the current profile.
GHRP-2
Snapshot captured 2026-09-27 — Evidence added or removed
Overview
Synthetic growth-hormone secretagogue and ghrelin-receptor agonist studied in endocrine challenge testing.
Evidence quality
Source identities are PubMed-resolved and provisionally graded by study design. Full-text findings, bias, applicability, contradictions, and regulatory interpretation remain pending.
Safety concerns
Hormonal surrogate outcomes are not general evidence of health benefit; product and regulatory context matter.
Citations as of this version
- Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.
- Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors. — PloS one (2022)
- Determination of the immunostimulatory drug-glucosoaminyl-muramyl-dipeptide-in human plasma using HPLC-MS/MS and its application to a pharmacokinetic study. — Biomedical chromatography : BMC (2020)
- Detection of black market follistatin 344. — Drug testing and analysis (2019)
- Glycine-modified growth hormone secretagogues identified in seized doping material. — Drug testing and analysis (2019)
- Analysis of new growth promoting black market products. — Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society (2018)
- Evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas. — Endocrine journal (2018)
- Structure-activity relationship for peptídic growth hormone secretagogues. — Drug testing and analysis (2017)
- Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels. — American journal of men's health (2017)
- Growth Hormone Releasing Peptide-2 Attenuation of Protein Kinase C-Induced Inflammation in Human Ovarian Granulosa Cells. — International journal of molecular sciences (2016)
- Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity. — AAPS PharmSciTech (2015)
- Intraportal infusion of ghrelin could inhibit glucose-stimulated GLP-1 secretion by enteric neural net in Wistar rat. — BioMed research international (2014)
- Metabolism of growth hormone releasing peptides. — Analytical chemistry (2012)
- Growth hormone-releasing peptide-2 stimulates secretion and synthesis of adrenocorticotropic hormone in mouse pituitary. — Regulatory peptides (2009)
- A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. — European journal of endocrinology (2007)
- KP-102 (growth hormone-releasing peptide-2) attenuates ischemia/reperfusion injury in isolated rat hearts. — Naunyn-Schmiedeberg's archives of pharmacology (2006)
- ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF. — Naunyn-Schmiedeberg's archives of pharmacology (2005)
- Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. — The Journal of clinical endocrinology and metabolism (2005)
- Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN. — Drugs in R&D (2004)
- General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. — Arzneimittel-Forschung (2004)
- Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. — Arzneimittel-Forschung (2004)
- The hexapeptide KP-102 (D-ala-D-beta-Nal-ala-trp-D-phe-lys-NH(2)) stimulates growth hormone release in a cichlid fish (Ooreochromis mossambicus). — The Journal of endocrinology (2000)
- Ipamorelin, the first selective growth hormone secretagogue. — European journal of endocrinology (1998)
- Growth hormone-releasing peptides. — European journal of endocrinology (1997)
- Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness. — Clinical endocrinology (1996)
- GH releasing peptides--structure and kinetics. — The Journal of pediatric endocrinology (1993)
Regulatory status as of this version
- United States: not_approved
- European Union: not_approved
Content hash: 2f06e3aeceed521fe9269f19d48d9c31b31c0c2fbd04651c8504088226fda6b8